Pharmacology

Action Mechanism of Action Reference
ANTISENSE INHIBITOR LPA mRNA antisense inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Hyperlipoproteinemias 3 D006951 ClinicalTrials
Cardiovascular Diseases 2 D002318 ClinicalTrials
Aortic Valve Stenosis 2 D001024 ClinicalTrials
Kidney Diseases 1 D007674 ClinicalTrials
Liver Diseases 1 D008107 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4298202
FDA SRS LSO9H7UZ90